Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BTKi”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03328078
What this trial is testing

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Who this might be right for
Relapsed Hematologic MalignancyRefractory Hematologic MalignancyRelapsed Primary Central Nervous System Lymphoma+1 more
Curis, Inc. 152
Early research (Phase 1)Study completedNCT01766583
What this trial is testing

A Phase IB Study Of The BTKi CC-292 Combined With Lenalidomide In Adults Patients With Relapsed/Refractory B-Cell Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Lymphoma
The Lymphoma Academic Research Organisation 18
Large-scale testing (Phase 3)Active Not RecruitingNCT04662255
What this trial is testing

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

Who this might be right for
Lymphoma, Mantle-Cell
Loxo Oncology, Inc. 500
Testing effectiveness (Phase 2)Looking for participantsNCT06466122
What this trial is testing

Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Kerry Rogers 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07526597
What this trial is testing

Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
UNC Lineberger Comprehensive Cancer Center 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04947319
What this trial is testing

Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)

Who this might be right for
Refractory Primary Central Nervous System LymphomaPrimary CNS Lymphoma
Ono Pharmaceutical Co., Ltd. 119
Not applicableUnknownNCT06130709
What this trial is testing

IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation

Who this might be right for
BTKi-induced Atrial FibrillationHematologic MalignancyAtrial Fibrillation Catheter Ablation
University Hospital, Caen 100